Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial.

PubWeight™: 3.31^‹?› | Rank: Top 1%

🔗 View Article (PMID 30528472)

Published in Lancet on December 05, 2018

Authors

FOCUS Trial Collaboration

Associated clinical trials:

Escitalopram and Language Intervention for Subacute Aphasia (ELISA) | NCT03843463

Articles citing this ↘

Fluoxetine and recovery after stroke. Lancet (2018) 0.75

Routine fluoxetine in stroke. BMJ Evid Based Med (2019) 0.75

FOCUS trial: results, potentialities and limits. Ann Transl Med (2019) 0.75

Fluoxetine in stroke (FOCUS) trial-reasons to be cheerful about antidepressants in stroke? Ann Transl Med (2019) 0.75